etidronate has been researched along with Cystic Fibrosis of Pancreas in 3 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Excerpt | Relevance | Reference |
---|---|---|
"Disturbances in bone mineralization are frequent in cystic fibrosis but few studies have focused on the use of biphosphonates in this indication, and none on the use of oral etidronate." | 3.72 | [Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density]. ( Audran, M; Duveau, E; Giniès, JL; Leblanc, M; Leboucher, B; Ringuier, B; Troussier, F, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haworth, CS | 1 |
Sharples, L | 1 |
Hughes, V | 1 |
Elkin, SL | 1 |
Hodson, ME | 1 |
Conway, SP | 1 |
Etherington, C | 1 |
Elborn, JS | 1 |
Rendall, J | 1 |
Wheaton, E | 1 |
Kadri, E | 1 |
Elliott, J | 1 |
Barker, HC | 1 |
Bearcroft, PW | 1 |
Hlaing, T | 1 |
Compston, JE | 1 |
Ringuier, B | 1 |
Leboucher, B | 1 |
Leblanc, M | 1 |
Troussier, F | 1 |
Duveau, E | 1 |
Audran, M | 1 |
Giniès, JL | 1 |
Carson, MR | 1 |
Winter, MC | 1 |
Travis, SM | 1 |
Welsh, MJ | 1 |
1 trial available for etidronate and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Cystic Fibrosis; Drug Administration Schedule | 2011 |
2 other studies available for etidronate and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
[Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density].
Topics: Adult; Bone Density; Calcium; Child; Cystic Fibrosis; Dietary Supplements; Etidronic Acid; Humans; R | 2004 |
Pyrophosphate stimulates wild-type and mutant cystic fibrosis transmembrane conductance regulator Cl- channels.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Membrane; Chloride Channels; Cyclic AMP; Cyclic AMP | 1995 |